CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale EVP & Chief Commercial Officer sold 7,898 shares at an average $25.21 ($199,132)
- 4 Shares withheld for taxes EVP and General Counsel gave up 5,858 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Officer gave up 7,144 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 23,786 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 8,491 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 2,300 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Grant or award President and CEO acquired 133,989 shares (grant or award)
- 4/A Grant or award Chief Technology Officer acquired 51,889 shares (grant or award)
- 4/A Grant or award EVP & Chief Commercial Officer acquired 51,945 shares (grant or award)
- 4/A Grant or award Executive Vice President & CFO acquired 50,161 shares (grant or award)
- 4/A Open-market sale EVP and General Counsel sold 6,081 shares at $24.45 ($148,680)
- 4/A Grant or award EVP and Chief Medical Officer acquired 39,147 shares (grant or award)
Page 22 of 44 · 872 filings